Abstract
ThyroidVol. 19, No. 11 Letters to the EditorProcalcitonin Can Be Used for Monitoring Sepsis in Patients with Medullary Thyroid CarcinomaAlexander R. Novotny, Peter Luppa, Robert Rosenberg, H. Schneider, Matthias Maak, Holger Bartels, Bernhard Holzmann, and Helmut FriessAlexander R. NovotnyDepartment of Surgery, Technical University of Munich, Munich, Germany.Search for more papers by this author, Peter LuppaInstitute of Clinical Chemistry and Pathobiochemistry, Technical University of Munich, Munich, Germany.Search for more papers by this author, Robert RosenbergDepartment of Surgery, Technical University of Munich, Munich, Germany.Search for more papers by this author, H. SchneiderInstitute of Clinical Chemistry and Pathobiochemistry, Technical University of Munich, Munich, Germany.Search for more papers by this author, Matthias MaakDepartment of Surgery, Technical University of Munich, Munich, Germany.Search for more papers by this author, Holger BartelsDepartment of Surgery, Technical University of Munich, Munich, Germany.Search for more papers by this author, Bernhard HolzmannDepartment of Surgery, Technical University of Munich, Munich, Germany.Search for more papers by this author, and Helmut FriessDepartment of Surgery, Technical University of Munich, Munich, Germany.Search for more papers by this authorPublished Online:4 Nov 2009https://doi.org/10.1089/thy.2009.0093AboutSectionsView articleView Full TextPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited ByProcalcitonin measured by three different assays is an excellent tumor marker for the follow-up of patients with medullary thyroid carcinoma14 July 2021 | Clinical Chemistry and Laboratory Medicine (CCLM), Vol. 59, No. 11Procalcitonin as an Alternative Tumor Marker of Medullary Thyroid Carcinoma12 August 2021 | The Journal of Clinical Endocrinology & Metabolism, Vol. 25Uso della procalcitonina come marker del carcinoma midollare tiroideo2 August 2018 | La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine, Vol. 14, No. 4Procalcitonin as a postoperative marker in the follow-up of patients affected by medullary thyroid carcinoma30 April 2018 | The International Journal of Biological Markers, Vol. 33, No. 2Procalcitonin as Marker of Recurrent Medullary Thyroid Carcinoma: A Systematic Review and Meta-AnalysisEndocrinology and Metabolism, Vol. 33, No. 2Procalcitonin for detecting medullary thyroid carcinoma: a systematic reviewEndocrine-Related Cancer, Vol. 22, No. 3Basal and Stimulated Calcitonin and Procalcitonin by Various Assays in Patients with and without Medullary Thyroid Cancer1 March 2011 | Clinical Chemistry, Vol. 57, No. 3 Volume 19Issue 11Nov 2009 InformationCopyright 2009, Mary Ann Liebert, Inc.To cite this article:Alexander R. Novotny, Peter Luppa, Robert Rosenberg, H. Schneider, Matthias Maak, Holger Bartels, Bernhard Holzmann, and Helmut Friess.Procalcitonin Can Be Used for Monitoring Sepsis in Patients with Medullary Thyroid Carcinoma.Thyroid.Nov 2009.1287-1289.http://doi.org/10.1089/thy.2009.0093Published in Volume: 19 Issue 11: November 4, 2009Online Ahead of Print:September 28, 2009PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
